Tinlarebant 5 mg´s matching Placebo, LBS-008
LBS-008-CT03
Phase 3 small_molecule active
Quick answer
Tinlarebant 5 mg´s matching Placebo, LBS-008 for Stargardt Disease is a Phase 3 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ELITE PHARMACEUTICALS INC /NV/
- Indication
- Stargardt Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active